These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26122249)

  • 1. PPI-Refractory GERD: an Intriguing, Probably Overestimated, Phenomenon.
    Baldi F
    Curr Gastroenterol Rep; 2015 Jul; 17(7):451. PubMed ID: 26122249
    [No Abstract]   [Full Text] [Related]  

  • 2. Refractory GERD: what is it?
    Fass R; Gasiorowska A
    Curr Gastroenterol Rep; 2008 Jun; 10(3):252-7. PubMed ID: 18625135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Refractory gastroesophageal reflux disease (GERD) and PPI safety].
    Huerta-Iga FM
    Rev Gastroenterol Mex; 2013 Aug; 78 Suppl 1():1-3. PubMed ID: 24041041
    [No Abstract]   [Full Text] [Related]  

  • 4. [Reasons for proton-pump-inhibitor failure in the treatment of gastroesophageal reflux disease].
    Juhász M; Tulassay Z
    Orv Hetil; 2008 Oct; 149(40):1881-8. PubMed ID: 18815107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with refractory reflux symptoms: What do they have and how should they be managed?
    Kahrilas PJ; Keefer L; Pandolfino JE
    Neurogastroenterol Motil; 2015 Sep; 27(9):1195-201. PubMed ID: 26303047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of proton pump inhibitors for the treatment of gastroesophageal reflux disease.
    Friedlander EA; Pallentino J; Miller SK; VanBeuge SS
    J Am Acad Nurse Pract; 2010 Dec; 22(12):674-83. PubMed ID: 21129076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of proton-pump inhibitor-refractory non-erosive reflux disease according to multichannel intraluminal impedance-pH monitoring.
    Kohata Y; Fujiwara Y; Machida H; Okazaki H; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
    J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():58-62. PubMed ID: 22486873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proton pump inhibitors in gastro-oesophageal reflux disease: what is the further step?].
    Simon M; Zerbib F
    Presse Med; 2013; 42(7-8):1081-4. PubMed ID: 23079391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In patients with typical symptoms of GERD and without alarm symptoms, what are the most appropriate dose and duration of empirical PPI therapy that would allow a definitive diagnosis of GERD?].
    Ponce M
    Gastroenterol Hepatol; 2009 Feb; 32(2):126-7. PubMed ID: 19231690
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel endoscopic submucosal dissection technique for proton pump inhibitor-refractory gastroesophageal reflux disease.
    Ota K; Takeuchi T; Harada S; Edogawa S; Kojima Y; Inoue T; Higuchi K
    Scand J Gastroenterol; 2014 Dec; 49(12):1409-13. PubMed ID: 25384555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Insufficient symptom control under long-term treatment with PPI in GERD - fact or fiction?].
    Labenz J; Labenz G; Stephan D; Willeke F;
    MMW Fortschr Med; 2016 May; 158 Suppl 4():7-11. PubMed ID: 27221555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of baseline impedance in patients with proton pump inhibitor-refractory nonerosive reflux disease.
    Kohata Y; Fujiwara Y; Yamagami H; Tanigawa T; Shiba M; Watanabe K; Watanabe T; Tominaga K; Arakawa T
    J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():36-40. PubMed ID: 25827802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of duodenogastroesophageal reflux in gastroesophageal reflux disease patients refractory to proton pump inhibitor therapy.
    Kunsch S; Neesse A; Linhart T; Nell C; Gress TM; Ellenrieder V
    Digestion; 2012; 86(4):315-22. PubMed ID: 23128301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic work-up of GERD.
    Vela MF
    Gastrointest Endosc Clin N Am; 2014 Oct; 24(4):655-66. PubMed ID: 25216910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.
    Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND
    Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of gastro-oesophageal reflux disease symptoms that do not respond to proton pump inhibitors.
    Woodland P; Sifrim D
    Curr Opin Gastroenterol; 2013 Jul; 29(4):431-6. PubMed ID: 23549342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastroesophageal reflux disease: endoscopy, duration of treatment, and choice of PPI.
    Greenspan NR
    Med Health R I; 2011 Apr; 94(4):92-4. PubMed ID: 21667598
    [No Abstract]   [Full Text] [Related]  

  • 19. [How to choose correct proton pump inhibitors to patients with GERD?].
    Bordin DS
    Eksp Klin Gastroenterol; 2010; (2):53-8. PubMed ID: 20496811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Let's stop proton pump inhibitor prescriptions for suspected GERD in non-validated indications!].
    Mouterde O; Chouraqui JP; Ruemmele F; Mas E; Bellaïche M; ; ; Faure C; Gottrand F; Tounian P
    Arch Pediatr; 2014 Jul; 21(7):686-9. PubMed ID: 24938917
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.